Literature DB >> 25462645

Protein carbonylation after traumatic brain injury: cell specificity, regional susceptibility, and gender differences.

Rachel C Lazarus1, John E Buonora1, David M Jacobowitz2, Gregory P Mueller3.   

Abstract

Protein carbonylation is a well-documented and quantifiable consequence of oxidative stress in several neuropathologies, including multiple sclerosis, Alzheimer׳s disease, and Parkinson׳s disease. Although oxidative stress is a hallmark of traumatic brain injury (TBI), little work has explored the specific neural regions and cell types in which protein carbonylation occurs. Furthermore, the effect of gender on protein carbonylation after TBI has not been studied. The present investigation was designed to determine the regional and cell specificity of TBI-induced protein carbonylation and how this response to injury is affected by gender. Immunohistochemistry was used to visualize protein carbonylation in the brains of adult male and female Sprague-Dawley rats subjected to controlled cortical impact (CCI) as an injury model of TBI. Cell-specific markers were used to colocalize the presence of carbonylated proteins in specific cell types, including astrocytes, neurons, microglia, and oligodendrocytes. Results also indicated that the injury lesion site, ventral portion of the dorsal third ventricle, and ventricular lining above the median eminence showed dramatic increases in protein carbonylation after injury. Specifically, astrocytes and limited regions of ependymal cells adjacent to the dorsal third ventricle and the median eminence were most susceptible to postinjury protein carbonylation. However, these patterns of differential susceptibility to protein carbonylation were gender dependent, with males showing significantly greater protein carbonylation at sites distant from the lesion. Proteomic analyses were also conducted and determined that the proteins most affected by carbonylation in response to TBI include glial fibrillary acidic protein, dihydropyrimidase-related protein 2, fructose-bisphosphate aldolase C, and fructose-bisphosphate aldolase A. Many other proteins, however, were not carbonylated by CCI. These findings indicate that there is both regional and protein specificity in protein carbonylation after TBI. The marked increase in carbonylation seen in ependymal layers distant from the lesion suggests a mechanism involving the transmission of a cerebral spinal fluid-borne factor to these sites. Furthermore, this process is affected by gender, suggesting that hormonal mechanisms may serve a protective role against oxidative stress. Published by Elsevier Inc.

Entities:  

Keywords:  Astrocytes; Carbonylation; Dorsal third ventricle; Ependymal cells; Free radicals; Median eminence; Reactive carbonyl species; Reactive oxygen species; Traumatic brain injury

Mesh:

Substances:

Year:  2014        PMID: 25462645     DOI: 10.1016/j.freeradbiomed.2014.10.507

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  17 in total

1.  Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.

Authors:  Glen Acosta; Nicholas Race; Seth Herr; Joseph Fernandez; Jonathan Tang; Edmond Rogers; Riyi Shi
Journal:  Mol Cell Neurosci       Date:  2019-06-12       Impact factor: 4.314

Review 2.  Epigenetics in acute kidney injury.

Authors:  Jinhua Tang; Shougang Zhuang
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-07       Impact factor: 2.894

3.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

Review 4.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

5.  Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy.

Authors:  Tyler G Demarest; Rosemary A Schuh; Jaylyn Waddell; Mary C McKenna; Gary Fiskum
Journal:  J Neurochem       Date:  2016-05-06       Impact factor: 5.372

6.  T-cell factor (TCF/LEF1) binding elements (TBEs) of FasL (Fas ligand or CD95 ligand) bind and cluster Fas (CD95) and form complexes with the TCF-4 and b-catenin transcription factors in vitro and in vivo which result in triggering cell death and/or cell activation.

Authors:  Xia Liu; Yuwei Huang; Yuanyuan Zhang; Xiaohong Li; Chun Liu; Shen Huang; Dezhi Xu; Yang Wu; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2016-04-18       Impact factor: 5.046

Review 7.  Central Nervous System Injury and Nicotinamide Adenine Dinucleotide Phosphate Oxidase: Oxidative Stress and Therapeutic Targets.

Authors:  Ramona E von Leden; Young J Yauger; Guzal Khayrullina; Kimberly R Byrnes
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

Review 8.  Oxidized phospholipid signaling in traumatic brain injury.

Authors:  Tamil S Anthonymuthu; Elizabeth M Kenny; Andrew M Lamade; Valerian E Kagan; Hülya Bayır
Journal:  Free Radic Biol Med       Date:  2018-06-30       Impact factor: 7.376

9.  Fluorescence labeling of carbonylated lipids and proteins in cells using coumarin-hydrazide.

Authors:  Venukumar Vemula; Zhixu Ni; Maria Fedorova
Journal:  Redox Biol       Date:  2015-04-23       Impact factor: 11.799

10.  Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.

Authors:  Rachel C Lazarus; John E Buonora; Michael N Flora; James G Freedy; Gay R Holstein; Giorgio P Martinelli; David M Jacobowitz; Gregory P Mueller
Journal:  Front Neurol       Date:  2015-09-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.